Complement protein holds diagnostic, prognostic promise in lung cancer

A complement activation product known as “C4d” may have value as a diagnostic and prognostic biomarker for lung cancer, research suggests.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news